Find Grants for Native American & Tribal Governments
Find out if you qualify for verified grants for Native American & Tribal Governments. Discover your eligibility and key funding details for Native American & Tribal Governments from major foundations and government agencies.
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-233
Agency: National Institutes of Health
Open Date: October 30, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.399, 93.242, 93.121, 93.279, 93.310, 93.113, 93.853, 93.172, 93.989, 93.273, 93.865, 93.866
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
Deadline: July 14, 2026
Opportunity Number: PAR-24-313
Agency: National Institutes of Health
Open Date: October 30, 2024
Close Date: July 14, 2026
Status: Posted
CFDA Numbers: 93.213
Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-185
Agency: National Institutes of Health
Open Date: October 30, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865, 93.121, 93.351
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
Deadline: July 14, 2026
Opportunity Number: PAR-24-312
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: July 14, 2026
Status: Posted
CFDA Numbers: 93.213
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
Deadline: April 15, 2027
Opportunity Number: PAR-25-131
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: April 15, 2027
Status: Posted
CFDA Numbers: 93.879
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-144
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.279, 93.242, 93.273, 93.866, 93.847, 93.307, 93.172, 93.846, 93.399, 93.853, 93.837, 93.361, 93.867, 93.855, 93.213, 93.121, 93.865, 93.113, 93.839, 93.840, 93.233, 93.838, 93.310
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
Deadline: June 1, 2027
Opportunity Number: PAR-24-264
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: June 1, 2027
Status: Posted
CFDA Numbers: 93.351, 93.859, 93.286
Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
Deadline: June 1, 2027
Opportunity Number: PAR-24-326
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: June 1, 2027
Status: Posted
CFDA Numbers: 93.351, 93.859
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
Deadline: June 1, 2027
Opportunity Number: PAR-24-265
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: June 1, 2027
Status: Posted
CFDA Numbers: 93.351, 93.286, 93.866, 93.242, 93.867, 93.859
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
Deadline: January 28, 2027
Opportunity Number: PAR-25-053
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: January 28, 2027
Status: Posted
CFDA Numbers: 93.853
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-024
Agency: National Institutes of Health
Open Date: October 28, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.853, 93.866
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)
Deadline: November 5, 2027
Opportunity Number: PAR-25-149
Agency: National Institutes of Health
Open Date: October 28, 2024
Close Date: November 5, 2027
Status: Posted
CFDA Numbers: 93.853
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
Deadline: November 16, 2027
Opportunity Number: PAR-25-122
Agency: National Institutes of Health
Open Date: October 28, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.121, 93.853, 93.173, 93.350, 93.855, 93.242
BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
Deadline: June 15, 2027
Opportunity Number: RFA-MH-26-140
Agency: National Institutes of Health
Open Date: October 23, 2024
Close Date: June 15, 2027
Status: Posted
CFDA Numbers: 93.286, 93.173, 93.867, 93.213, 93.273, 93.853, 93.866, 93.242, 93.865
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Deadline: January 6, 2028
Opportunity Number: PAR-25-057
Agency: National Institutes of Health
Open Date: October 23, 2024
Close Date: January 6, 2028
Status: Posted
CFDA Numbers: 93.121
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
Deadline: October 20, 2027
Opportunity Number: PAR-25-060
Agency: National Institutes of Health
Open Date: October 22, 2024
Close Date: October 20, 2027
Status: Posted
CFDA Numbers: 93.853
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
Deadline: October 20, 2027
Opportunity Number: PAR-25-059
Agency: National Institutes of Health
Open Date: October 22, 2024
Close Date: October 20, 2027
Status: Posted
CFDA Numbers: 93.853
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
Deadline: October 15, 2027
Opportunity Number: PAR-25-120
Agency: National Institutes of Health
Open Date: October 18, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.173
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Deadline: October 14, 2026
Opportunity Number: PAR-25-074
Agency: National Institutes of Health
Open Date: October 15, 2024
Close Date: October 14, 2026
Status: Posted
CFDA Numbers: 93.394
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
Deadline: October 14, 2026
Opportunity Number: PAR-25-075
Agency: National Institutes of Health
Open Date: October 15, 2024
Close Date: October 14, 2026
Status: Posted
CFDA Numbers: 93.394
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
Deadline: July 14, 2026
Opportunity Number: PAR-24-276
Agency: National Institutes of Health
Open Date: October 15, 2024
Close Date: July 14, 2026
Status: Posted
CFDA Numbers: 93.213
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
Deadline: December 3, 2026
Opportunity Number: PAR-24-296
Agency: National Institutes of Health
Open Date: October 15, 2024
Close Date: December 3, 2026
Status: Posted
CFDA Numbers: 93.989, 93.172, 93.867, 93.233, 93.866, 93.313, 93.839, 93.121, 93.838, 93.840, 93.853, 93.113, 93.398, 93.279, 93.242, 93.173, 93.837
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
Deadline: December 3, 2026
Opportunity Number: PAR-24-295
Agency: National Institutes of Health
Open Date: October 15, 2024
Close Date: December 3, 2026
Status: Posted
CFDA Numbers: 93.173, 93.313, 93.853, 93.172, 93.838, 93.866, 93.839, 93.279, 93.837, 93.398, 93.113, 93.233, 93.840, 93.242, 93.989
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
Deadline: January 6, 2028
Opportunity Number: PAR-25-062
Agency: National Institutes of Health
Open Date: October 10, 2024
Close Date: January 6, 2028
Status: Posted
CFDA Numbers: 93.121
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-098
Agency: National Institutes of Health
Open Date: October 10, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.399, 93.307, 93.121, 93.313
